Latest Breaking News On - Equity syndicate prospectus department - Page 18 : comparemela.com

Prime Medicine (PRME) Prices Upsized 19 2M Share Offering at $6 25/sh

Prime Medicine (PRME) Prices Upsized 19 2M Share Offering at $6 25/sh
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

New yorkUnited statesCapital markets corpExchange commissionBroadridge financial solutionsEquity syndicate departmentMedicine incEquity syndicate prospectus departmentJp morgan securitiesPrime medicineIsland avenueMarkets corp

KalVista Pharmaceuticals (KALV) Prices $160 1M Offering at $15 25/sh

KalVista Pharmaceuticals (KALV) Prices $160 1M Offering at $15 25/sh
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

New yorkUnited statesSan franciscoBryan bakerJarrod aldomSyndicate departmentCorporate communicationsLeerink partnersExchange commissionCantor fitzgerald coEquity syndicate prospectus departmentNicolaus company incorporatedDrug administrationNeedham companyKalvista pharmaceuticals incKalvista pharmaceuticals

KalVista Pharmaceuticals, Inc : KalVista Pharmaceuticals Announces Pricing of a $160 1 Million Public Offering of Common Stock and Pre-Funded Warrants

KalVista Pharmaceuticals, Inc : KalVista Pharmaceuticals Announces Pricing of a $160 1 Million Public Offering of Common Stock and Pre-Funded Warrants
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United statesSan franciscoNew yorkBryan bakerStefan klotterJarrod aldomEquity syndicate prospectus departmentKalvista pharmaceuticals incCantor fitzgerald coDrug administrationNeedham companyExchange commissionLeerink partnersNicolaus company incorporatedCorporate communicationsSyndicate department

KalVista Pharmaceuticals Announces Pricing of a $160 1 Million Public Offering of Common Stock and Pre-Funded Warrants

KalVista Pharmaceuticals Announces Pricing of a $160 1 Million Public Offering of Common Stock and Pre-Funded Warrants
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Mashonaland eastUnited kingdomUnited statesNew yorkSan franciscoBryan bakerJarrod aldomEquity syndicate prospectus departmentExchange commissionLeerink partnersSyndicate departmentKalvista pharmaceuticals incDrug administrationNicolaus company incorporatedCantor fitzgerald coNeedham company

NewAmsterdam Pharma Announces Pricing of $175 3 Million Public Offering of Ordinary Shares and Pre-Funded Warrants

NAARDEN, the Netherlands and MIAMI, Feb. 13, 2024 NewAmsterdam Pharma Company N.V. , a late-stage, clinical biopharmaceutical company developing oral, non-statin medicines for patients at risk.

Noord hollandNew yorkUnited statesPiper sandlerHannah deresiewiczPiper sandler coCapital marketsNeither the companyExchange commissionSyndicate departmentProspectus departmentEquity syndicate prospectus departmentLeerink partnersNewamsterdam pharma companynv nasdaqOrdinary sharesFunded warrants